| Literature DB >> 34007681 |
Nishat Afreen1, Eimeira Padilla-Tolentino2, Brandy McGinnis3.
Abstract
BACKGROUND ANDEntities:
Keywords: Electronic Health Records; High-risk medication errors; High-risk medications; Medication errors; Pharmacy; Telehealth; Telepharmacy; Web-based
Year: 2021 PMID: 34007681 PMCID: PMC8102974 DOI: 10.24926/iip.v12i1.3377
Source DB: PubMed Journal: Innov Pharm ISSN: 2155-0417
Figure 1.Ascension Texas Medication History Survey tool breakdown.
Abbreviations used: HR, high-risk.
Classifying Potential High-Risk Medications and Medication Errors by Drug Category
Cardiovascular | 175 | 39 | 101 | 39 |
Hypoglycemic | 58 | 13 | 40 | 15 |
CNS medications | 44 | 10 | 24 | 9 |
Antiplatelet (aspirin) | 39 | 9 | 23 | 9 |
Anticoagulant | 17 | 4 | 12 | 5 |
NSAIDs | 13 | 3 | 5 | 2 |
Corticosteroid (systemic) | 7 | 2 | 4 | 2 |
Antibiotic | 12 | 3 | 6 | 2 |
NTI | 7 | 2 | 5 | 2 |
Antiarrhythmic | 3 | 1 | 3 | 1 |
Cytostatic | 3 | 1 | 2 | 1 |
Immunosuppressant | 4 | 1 | 3 | 1 |
Antiretroviral | 6 | 1 | 3 | 1 |
Anti-rheumatic | 2 | 0 | 1 | 0 |
PIM CNS | 22 | 5 | 10 | 4 |
PIM Fall/Fracture | 15 | 3 | 9 | 3 |
PIM PPI | 12 | 3 | 6 | 2 |
PIM Anticholinergic | 7 | 2 | 3 | 1 |
PIM Endocrine | 2 | 0 | 0 | 0 |
PIM Antiplatelet | 0 | 0 | 0 | 0 |
PIM Electrolyte | 0 | 0 | 0 | 0 |
PIM Other | 0 | 0 | 0 | 0 |
Abbreviations used: NSAIDs, nonsteroidal anti-inflammatory drugs; CNS, central nervous system; NTI, narrow therapeutic index drugs; PIM, potentially inappropriate medication; PPI, proton-pump inhibitor
CNS: Medications that affect the central nervous system without fall risk. Includes opioids, benzodiazepines, and first/second generation antipsychotics
Hypoglycemic: Insulin and sulfonylureas
NTI: Narrow therapeutic index medications
Endocrine: Includes thyroid, estrogen, progesterone, and testosterone hormone medications
PIM CNS: Includes Adult CNS medications + antiepileptics, antidepressants, z-hypnotics, skeletal muscle relaxants, and meprobamate
PIM Fall/Fracture: Medications that affect the central nervous system and are associated with increased fall risk. Includes vasodilators, heral alpha blockers, and dipyridamole
PIM Electrolyte: Includes desmopressin and stimulant laxatives
PIM Other: Includes metoclopramide, mineral oil, and megestrol
High-Risk Medication Errors Categorized By Error Type
Omitted Entry | 119 |
Incorrect Entry | 82 |
Extra Entry | 31 |
Incomplete Entry | 28 |
Duplicate Entry | 1 |
Other Entry | 0 |
Data collected from 191 patients in emergency departments of Ascension Texas from April 2019 to October 2020.
Other: Error due to a medication allergy or intolerance listed in the patient’s electronic medical record.
Figure 2.High-Risk Medication Errors Categorized By Error Type
A total of 261 potential medication errors were identified from 191 patients in emergency departments of Ascension Texas from April 2019 to October 2020.
High-Risk Medications and Medication Error Frequencies
Total # of HR Medications | 448 |
Total # of All Medications | 1088 |
% of HR Medications | 41% |
Total # of HR Medication Errors | 261 |
Total # of All Medication Errors | 624 |
% of HR Medication Errors | 42% |
% HR medication orders that contain potential medication error | 58% |
% All medication orders that contain potential medication error | 57% |
Economic Impact of Preventing Potential Medication Errors During Pilot Period
Total # of potential HR medication errors | 261 |
Average cost-savings per error (in-hospital) in 2020 | $4532 |
Potential total cost savings to Ascension Texas in 18 months | $1,182,852 |
Estimated total cost savings to Ascension Texas per year (post-pilot) | $2,365,704 |